WASHINGTON, DC. – A top FDA official warned that additional closures of ethylene oxide (EtO) sterilization plants could lead to shortages of critical medical devices across the country.
Medela LLC, headquartered in McHenry, Illinois, today wrote to Illinois state house speaker Michael Madigan saying they “respectfully oppose HB 3888 and HB 3885 because their restriction to EO use would…
WASHINGTON, D.C. – AdvaMed® released a statement on FDA’s announcement today that the agency is concerned about medical device shortages in light of two recent closures of ethylene oxide sterilization…
The closure of medical device sterilization facilities will disrupt the health care supply chain in every state and territory in the US and cause serious public health consequences that will…
WASHINGTON, D.C. – This week, six leading medical groups sent a letter to FDA urging caution as regulators consider limiting the use of ethylene oxide (EtO) for medical device sterilization. The surgeons…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of AdvaMed®, today released a statement on Georgia’s filing of a temporary restraining order against BD’s medical device sterilization plant in Covington, Ga.
The Institute for Supply Management’s recently released September purchasing managers’ index – a key gauge of U.S. manufacturing strength – fell to its lowest reading in more than 10 years.…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), today sent a letter to U.S. President Donald J. Trump seeking his help as the…
WASHINGTON, DC. – The Advanced Medical Technology Association® (AdvaMed®) today announced the launch of its Center for Digital Health, a new advocacy platform designed to advance digital health and the contributions of…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on the Department of Health and Human Services’ issuance of a proposed…